PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study

Summary

This study is designed to evaluate whether a precision exercise regimen is feasible to implement within cancer populations, specifically stage II-III primary lung cancer patients receiving multimodal therapy, and delivered through telehealth.

Eligibility

Inclusion Criteria:

* Ages 18 and older at time of diagnosis
* Patient diagnosed with stage II and III non-small cell lung cancer (NSCLC)
* Patient receives either neoadjuvant chemotherapy or immunotherapy and surgery
* Patient able to follow direction and complete questionnaires in English or Spanish
* Patient agrees to complete the PERCC intervention

Exclusion Criteria:

* Morbidly obese (BMI \>40 kg/m2 ) or anorexic (BMI \<17.5 kg/m2 )
* Abnormalities on screening physical exam per study physicians or physical therapist to contraindicate participation in exercise program compliance
* Alcohol or drug abuse, significant mental or emotional problems that would interfere with compliance (assessed by NCCN Distress Thermometer)
* Patient scheduled to receive single modality cancer treatment (unimodal therapy), scheduled to begin treatment within 2 weeks of the pre-treatment clinic visit, or for whom treatment has already started

Conditions4

Locations2 sites

Browse More Trials